Adimmune Corporation reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 52.8 million compared to TWD 6.93 million a year ago. Net loss was TWD 234.61 million compared to TWD 249.8 million a year ago. Basic loss per share from continuing operations was TWD 0.55 compared to TWD 0.58 a year ago. Diluted loss per share from continuing operations was TWD 0.55 compared to TWD 0.58 a year ago. Basic loss per share was TWD 0.55 compared to TWD 0.58 a year ago. Diluted loss per share was TWD 0.55 compared to TWD 0.58 a year ago.